Medical education activities

Pharmaceutical companies can become involved with medical education activities via sponsored meetings and conferences, as well as paying for the authorship of reference texts and peer-reviewed journal articles. 

Outcome and quality improvement activities Continuing medical education... 

Treatment considerations for antiretroviral-experienced patients are much more complex than for patients who are naive to therapy. Prior to changing therapy, the reasons for treatment failure should be identified. A comprehensive review of the patient s severity of disease, antiretroviral treatment history, adherence to therapy, intolerance or toxicity, concomitant drug therapies, co-morbidities, and results of current and past HIV resistance testing should be performed. If patients fail therapy due to poor adherence, the underlying reasons must be determined and addressed prior to initiation of new therapy. Reasons for poor adherence include problems with medication access, active substance abuse, depression and/or denial of the disease, and a lack of education on the importance of 100%... 

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical College of Georgia School of Medicine and The University of Georgia College of Pharmacy. 

The Medical College of Georgia School of Medicine designates this educational activity for a maximum of 170 AMA PRA Category 1 Credits. Physicians (and other qualified participants) should only claim credit commensurate with the extent of their participation in the activity. 

More progressive MCOs have moved to concurrent DUR, in which a pharmacist can screen for drug incompatibilities, duplicate prescriptions, and other problems before dispensing the medication. Obviously, the prevention of problems or the intervention directly with patients is attractive. While the identification of drug-related problems is vital to managing pharmacotherapy, intervention with the prescriber or patient also is required. The most common approach to intervening with prescribers and patients is through educational activities. 

The meaning of the psychiatric illness to the child and his or her family should be considered. Denial and confusion about the illness may not be expressed directly. Specific points for medication education include (J) the reasons for medications being used, (2) the goals of medication and when they might be achieved (3) the common side effects and when they will emerge (4) the rare side effects and when they might emerge (5) the activities, foods, drinks, and other medications that are contraindicated or require caution (6) recommended parental response to potential side effects and (7) duration of treatment (Kutcher, 1997). 

The FDA has established authority over every word, footnote, picture and nuance of all promotional activities issued by or sponsored by drug companies. That includes promotion to the consumer, press materials, detailing aids, continuing medical education, seminars, materials for managed care organizations. The agency has jurisdiction over oral statements made by a company representative to a physician. 

Switzerland Must be of modest value and relevant to the professional activity of the recipient. Commercial discounts may be allowed No guidance found No guidance found Support for medical education is permitted with specific conditions attached. See code Appropriate honoraria for speakers and reimbursement of expenses are permitted Permitted with some specific conditions. See code... 

Computers have been used as a routine part of pharmacy practice for many years. Pharmacists use this technology in many ways. For example, computers can be used to interact with physician colleagues, track patient behaviors, or as tools to evaluate cost and effectiveness of medication regimens.Pharmacists have also investigated concordance between traditional and computerized patient records, and are now incorporating computers into patient assessment and educational activities. 

The Iranian biological weapons program has been embedded within Iran s extensive biotechnology and pharmaceutical industries so as to obscure its activities. The Iranian military has used medical, education, and scientific research organizations for many aspects of biological agent procurement, research, and production. 

---